On Wednesday, March 27, 2019, Italfarmaco joined Parent Project Muscular Dystrophy for a webinar to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

If you missed the live event, the recording can be found below. You can read the company’s latest newsletter (download).

 

Watch the Recording

About the presenter

• Paolo Bettica, MD, PhD
  Vice President, Research & Development
  Italfarmaco group